JACC Specialty Journals

JACC: Advances - Incidence and Predictors of Worsening Renal Function in Edoxaban-Treated Atrial Fibrillation Patients Within ETNA-AF-Europe Registry

04.24.2024 - By American College of CardiologyPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Commentary by Dr. Candice Silversides

More episodes from JACC Specialty Journals